Across TCGA pan-cancer cohorts, RNU1-82P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU1-82P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RNU1-82P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-82P expression acts as an unfavorable survival marker.

CHOL, UVM, and ACC are the cancer types where RNU1-82P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.019	0.800	<.001	72	view →
UVM	DFS	Tertile	All	0.079	0.746	<.001	54	view →
ACC	DFS	Tertile	All	0.066	0.667	.002	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
KIRP	OS	Tertile	III,IV	0.236	0.809	<.001	36	view →
THYM	OS	Tertile	II,III,IV	0.689	0.969	.009	36	view →
BLCA	OS	Tertile	All	0.215	0.592	.047	18	view →
LAML	DFS	Tertile	All	0.167	0.597	.005	18	view →
THCA	DFS	Tertile	II,III,IV	0.103	0.928	<.001	18	view →
MESO	DFS	Tertile	III,IV	0.078	0.376	.012	18	view →
UCEC	DFS	Tertile	IV	0.181	0.705	.009	18	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

Exploration

Same gene, other analysis: RNU1-82P tumor-vs-normal RNA expression · all RNU1-82P data types